The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease
Authors:
- Scott L LetendreSLScott L Letendre
- Mariana ChernerMCMariana Cherner
- Ronald J EllisRERonald J Ellis
- Jennifer Marquie-BeckJMJennifer Marquie-Beck
- Bryan GraggBGBryan Gragg
- Thomas MarcotteTMThomas Marcotte
- Robert K HeatonRHRobert K Heaton
- J Allen McCutchanJMJ Allen McCutchan
- Igor GrantIGIgor Grant
- 1 October 2005
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 19 (Suppl 3) , S72-S78
Abstract
To determine the effects of hepatitis C virus (HCV) infection on neuropsychological (NP) performance. Cross-sectional analysis of a prospectively enrolled cohort. A total of 239 HIV-seropositive and 287 HIV-seronegative subjects enrolled in prospective cohort studies at a single center. Subjects underwent standardized assessments, including comprehensive neuropsychological testing, substance use inventory neuromedical examination, venipuncture, and lumbar puncture. HCV antibody was measured in serum. In seropositive individuals, HCV RNA was measured in plasma and cerebrospinal fluid (CSF). HCV-seropositive subjects performed worse on neuropsychological testing and were almost twice as likely to be diagnosed as globally impaired, compared with those who were HCV seronegative. In a multivariate analysis, HCV, HIV, and methamphetamine dependence were independently associated with worse performance, even after adjusting for Centers for Disease Control stage and antiretroviral use. HCV-RNA levels in plasma were higher in those with memory, but not global, impairment. In cerebrospinal fluid, HCV RNA was below 100 copies/ml in all specimens. In HIV-infected subjects, HCV was associated with higher levels of HIV RNA in CSF, but not in plasma. HCV was also associated with higher levels of monocyte chemotactic protein 1, TNF-α, and soluble TNF receptor II. HCV-seropositive subjects did not appear to have advanced liver disease. HIV, HCV, and methamphetamine independently injure the central nervous system, leading to global neuropsychological impairment. HCV may injure the brain by viral or immune-mediated mechanisms. HCV-associated brain injury may be preventable or reversible because HCV infection is potentially curable.Keywords
This publication has 18 references indexed in Scilit:
- Neuropsychiatric impact of hepatitis C on advanced HIVNeurology, 2004
- Hepatitis C virus infection is associated with reduced white matter N-acetylaspartate in abstinent methamphetamine usersJournal of the International Neuropsychological Society, 2004
- Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis CJournal of the International Neuropsychological Society, 2003
- Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International PanelAIDS, 2002
- Neuropsychological impairment in patients with chronic hepatitis CHepatology, 2002
- Hepatitis C and cognitive impairment in a cohort of patients with mild liver diseaseHepatology, 2002
- Study of the infection of human blood derived monocyte/macrophages with hepatitis C virus in vitroJournal of Medical Virology, 2001
- Applications of magnetic resonance spectroscopy to chronic liver diseaseClinical Medicine, 2001
- Management of chronic hepatitis C in HIV-infected patientsAIDS, 1999
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998